The
Softgel capsule market Size was valued at USD 7.3 billion in 2021 and is
projected to grow from USD 7.87 Billion in 2022 to USD 13.9 billion by 2032,
exhibiting a compound annual growth rate (CAGR) of 7.7% during the forecast
period (2023 - 2032).
The
softgel capsule market continues its upward trajectory fueled by
expanding applications across pharmaceuticals, nutraceuticals, and
cosmeceuticals. With rising consumer preference for easy-to-swallow, convenient
dosage forms, softgel capsules offer enhanced bioavailability and stability for
various formulations. Increased awareness of health and wellness supplements
amplifies demand, propelling market growth globally. Advancements in capsule
technology, including improved ingredients and customization options, drive
innovation. Regulatory approvals and stringent quality standards remain pivotal
in shaping market dynamics. Emerging trends like plant-based formulations and
sustainable packaging solutions gain traction, reflecting evolving consumer
preferences. The softgel capsule market is poised for sustained expansion
amidst evolving industry landscapes.
The
softgel capsule market is witnessing a significant surge, driven by the
increasing consumer preference for convenient and easy-to-swallow dietary
supplements. Among the myriad offerings in this market, vitamin C softgels and
vitamin B complex softgels stand out as prominent segments, catering to diverse
consumer health needs.
Vitamin C softgels are gaining traction due to their renowned
antioxidant properties, supporting immune health, collagen synthesis, and
overall vitality. With consumers becoming more health-conscious, the demand for
vitamin C softgels has soared, fueled by their convenience and potent health
benefits.
Similarly,
vitamin B complex softgels offer a comprehensive solution for maintaining
optimal energy levels, cognitive function, and nerve health. This blend of
essential B vitamins, including B1, B2, B3, B5, B6, B7, B9, and B12, addresses
various aspects of well-being, making it a sought-after supplement in the
market.
As
the softgel capsule market expands, manufacturers are innovating to meet
consumer preferences, offering enhanced formulations, improved bioavailability,
and sustainable sourcing practices. Moreover, stringent quality standards and
certifications ensure the safety and efficacy of these products, further
bolstering consumer trust and confidence.
Softgel
Capsule Market Segmentation
The
global soft gel capsule has been segmented based on type and application.
Based
on type, the soft gel capsule market is segmented into gelatin type and
non-animal type. The gelatin type segment is expected to grow as the largest
market share, owing to their easy-to-use features for the administration of
drugs orally or with the use of inhalation routes. The non-animal types segment
is projected to witness a comparatively higher CAGR during the forecast period.
On
the basis of application, the softgel market has been segmented into nutrition,
supplement, and vitamins. The vitamins segment is expected to contribute to
more than 30% of the market share during the forecast period, owing to the
increased prevalence of vitamin deficiency, which is expected to fuel the
growth of the segment. The nutrition segment is expected to exhibit the highest
CAGR over the forecast period, owing to the high malnutrition rate
underdeveloped and developing countries, leading governments to initiate
awareness programs and subsidies products.
Softgel
Capsule Market Regional Analysis
Based
on the region, the global soft gel capsule market has been segmented into North
America, Europe, Asia Pacific (APAC), Latin America (LATAM), and the Middle
East and Africa (MEA).
North
America is the largest region in the global soft gel capsule market and is
expected to sustain its market standing over the forecast period, owing to the
growing preference of capsules dosage among consumers, growth in consumer
awareness regarding the benefits of nutraceutical products to prevent
significant health disorders, established pharmaceutical in the region, and the
increasing government initiatives to ensure the superior quality of medical
facilities offered to the consumers.
Europe
is one of the significant regions in the global market for soft gel capsules
and is expected to contribute substantially to the market share over the
forecast period, owing to the established healthcare sector, accessibility of
superior medical facilities,and the increasing health consciousness among
consumers.
The
Asia Pacific is the fastest growing regions in the global soft gel capsule
market, owing to the government initiatives to enhance the healthcare sectors,
especially in emerging economies such as India, Japan, and China.
The
Middle East and Africa (MEA) region is expected to witness gradual growth of
the forecast period and account for the smallest market share, due to the weak
healthcare sector in Africa, and unfavorable factors for market growth such as
weak economic and political conditions. The developing Middle Eastern countries
such as Saudi Arabia and the United Arab Emirates are expected to contribute to
the majority of the market share, owing to the presence of a developing
healthcare and pharmaceutical sectors.
Key
Players
Softgel Capsule Companies are Amway, Capsugel (a part of Lonza),
Captek softgel International Inc., Catalent, Inc., EuroCaps Ltd. (part of the
DCC plc Group), International Vitamin Corporation, Patheon (part of Thermo
fisher scientific), Sirio Pharma Co. Ltd., Soft Gel Technologies, Inc., Strides
Pharma Science Limited, Weihai Baihe Biology Technological Co. Ltd.
Related Reports:
Medical Rubber and Balloon
Products
Europe Pediatric Neurology
Devices
Cell Cycle Analysis
Olanzapine
Canisters
For More Information, Please Visit @ Market Research Future
Comments
Post a Comment